Standout Papers

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients W... 2018 2026 2020 2023 422
  1. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors (2018)
    Jason J. Luke, Jeffrey M. Lemons et al. Journal of Clinical Oncology

Immediate Impact

11 from Science/Nature 61 standout
Sub-graph 1 of 24

Citing Papers

Regulation of the cGAS-STING Pathway
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
2 intermediate papers

Works of Jeffrey M. Lemons being referenced

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
2018 Standout

Author Peers

Author Last Decade Papers Cites
Jeffrey M. Lemons 397 207 51 151 8 506
Nathan Comeaux 421 288 38 129 8 527
Kobe Reynders 376 208 29 164 12 528
Maria Cristina Bruna 234 254 18 97 13 471
Xiaohong Wang 330 142 15 192 12 471
Catherine Wadsworth 426 406 18 72 17 540
B. Adam 138 254 18 40 13 499
Carol Felix 249 187 47 88 14 535
Patrick M. Travis 228 343 57 27 10 472
Joseph M. Colasanto 165 375 98 37 12 550
Pooja Patel 220 188 19 50 13 461

All Works

Loading papers...

Rankless by CCL
2026